Others

Torrent Pharmaceuticals Ltd. - USFDA Classifies Inspection At Dahej Facility As OAI

| Updated on July 17, 2019 Published on July 17, 2019

The Company has received a communication from the USFDA classifying the inspection conducted at its Dahej facility in March, 2019 as Official Action Initiated (OAI).

The Company already had submitted its initial response to USFDA and commitments given in response to Form 483 observations have been fulfilled. The Company is sending further updates over receiving of this OAI letter. The Company will be engaging with the regulator and is fully committed in resolving this issue at the earliest.

The Company does not believe that this inspection classification will have an impact of disruption of supplies or the revenues from operations of this facility.

This is for your information and record.

Pdf Link: Torrent Pharmaceuticals Ltd. - USFDA Classifies Inspection At Dahej Facility As OAI

Source : BSE - www.bseindia.com

Published on July 17, 2019
This article is closed for comments.
Please Email the Editor